Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ardelyx, Inc. (ARDX) Investigation
Ardelyx wins FDA approval for phosphate absorption inhibitor - Pharmaceutical Technology
News & Events | Ardelyx, Inc.
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million Financing Agreement with…
Ardelyx
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT | MarketScreener
SEC Filing | Ardelyx, Inc.
Ardelyx to Raise $110 Million in a Private Placement
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire
Ardelyx
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit
Ardelyx
🦍💎 $ARDX ✋🚀
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy
Ardelyx Grants Stock Options & RSUs to New Employees
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug | BioSpace
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review
Ardelyx (@ardelyx) / X
